MeOmics
Home
The Science
Investing
The Team
MeOmics
Home
The Science
Investing
The Team
More
  • Home
  • The Science
  • Investing
  • The Team
  • Home
  • The Science
  • Investing
  • The Team

MeOmics, transforming mental healthcare

MeOmics' mission is to improve the diagnosis and treatment of mental health illnesses through combining unique neuronal cell assays and data-rich descriptors of individual patients including genomics.

This will allow preclinical screening, prior to expensive phase III drug trials, and will also enable clinical screening of patients leading to personalised mental healthcare, shortening the time and cost to better patient outcomes.
Having proved the technology in an academic setting, we are now seeking funding to progress the scale-up of the process and technology as an exciting and high-growth potential bio-tech start-up.

The Science

The Science

The Science

Pre/post clinical screening service

Learn more

Investing

The Science

The Science

We are excited to hear from any potential investors

Learn more

The Team

The Science

The Team

Meet the brilliant people behind MeOmics

Learn more

Our Partners

Copyright © 2021 MeOmics Technology Ltd. - All Rights Reserved.

  • Privacy Policy

Powered by GoDaddy